|
|
|
| Best In Class – Small Molecule API | The CDMO Leadership Awards are based on feedback from biopharma sponsor companies and independently analyzed by Tufts Center for the Study of Drug Development. MilliporeSigma is proud to announce their distinction as 2026’s Best In Class CDMO for Technology Use in the development of Small Molecule API. To learn more about how they can help with your next small molecule development project, click here. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | After acquiring PharmaSource and CDMO Live, we're back in live events. Their co-founders discuss where the outsourcing industry stands today—and what’s next for in-person and virtual events.
| |
|
|
|
By Brandon Miller and Natalie Pollock, Clarkston Consulting | The shortage-driven production of GLP-1 drugs of the past few years is giving way to a long-term operation model characterized by digital enablement and supply chain resilience. | |
|
|
|
|
|
| What's Next For Pharma Packaging? | Article | By Scott Mills and Armando Pedoto, Sr., Adare Pharma Solutions | From smart technologies to patient-centric design, learn how leading trends are transforming pharmaceutical packaging and delivery solutions. |
|
|
| The Commercial Advantage Of Softgels | Article | By Fergus Binnie, Douglas CDMO | Among oral dosage forms, softgel capsules stand out as a versatile and high-performance option — offering superior delivery characteristics, consumer appeal, and brand differentiation. |
|
|
|
|
|
| Outsourced Pharma Capabilities Update July 2026: Fill/Finish (July 29, 11am ET) | Explore the latest fill/finish capabilities from leading CDMOs, including sterile filling, lyophilization, and advanced packaging. This session highlights available capacity, global facilities, and timelines to support your development and manufacturing needs. Learn how quality control and regulatory compliance ensure product integrity, with concise presentations designed to help biopharma teams connect with partners and make informed outsourcing decisions. Register. |
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
|
|
|
| Join this Outsourced Pharma Live discussion: Charting a Direct Pathway from Academia To CDMOs on August 4, 2026 to learn how academic innovators, technology transfer offices, and CDMOs can bridge critical gaps in documentation, quality expectations, and development strategy. Hear practical advice on creating stronger technical packages, aligning earlier with CDMO partners, and accelerating the path from promising research to real-world manufacturing success. Register. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
